Oxaliplatin
NDC 67184-0510, Oxaliplatin, injection, solution, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0510
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204368
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0510 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXALIPLATIN200 mg/40mL
Pharmacologic classes
Platinum-based Drug [EPC]; Platinum-containing Compounds [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67184-0510-1 | 67184051001 | 1 VIAL, SINGLE-USE in 1 CARTON (67184-0510-1) / 40 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/33d4f4b4-bb4e-46af-9e89-df20154436d0
Use it
Look up 67184-0510 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0510 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0510. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.